Logo image of S30.PA

SOLUTIONS 30 SE (S30.PA) Stock Fundamental Analysis

Europe - EPA:S30 - FR0013379484 - Common Stock

1.043 EUR
+0.01 (+0.58%)
Last: 9/22/2025, 11:45:14 AM
Fundamental Rating

3

Taking everything into account, S30 scores 3 out of 10 in our fundamental rating. S30 was compared to 71 industry peers in the IT Services industry. S30 has a bad profitability rating. Also its financial health evaluation is rather negative. S30 may be a bit undervalued, certainly considering the very reasonable score on growth


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year S30 has reported negative net income.
S30 had a positive operating cash flow in the past year.
In multiple years S30 reported negative net income over the last 5 years.
In the past 5 years S30 always reported a positive cash flow from operatings.
S30.PA Yearly Net Income VS EBIT VS OCF VS FCFS30.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M

1.2 Ratios

The Return On Assets of S30 (-2.23%) is worse than 73.24% of its industry peers.
With a Return On Equity value of -17.03%, S30 is not doing good in the industry: 73.24% of the companies in the same industry are doing better.
The Return On Invested Capital of S30 (3.88%) is worse than 67.61% of its industry peers.
Industry RankSector Rank
ROA -2.23%
ROE -17.03%
ROIC 3.88%
ROA(3y)-4.19%
ROA(5y)-0.94%
ROE(3y)-25.27%
ROE(5y)-8.32%
ROIC(3y)N/A
ROIC(5y)N/A
S30.PA Yearly ROA, ROE, ROICS30.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20

1.3 Margins

S30 has a Operating Margin of 1.40%. This is in the lower half of the industry: S30 underperforms 73.24% of its industry peers.
In the last couple of years the Operating Margin of S30 has declined.
With an excellent Gross Margin value of 90.17%, S30 belongs to the best of the industry, outperforming 84.51% of the companies in the same industry.
S30's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 1.4%
PM (TTM) N/A
GM 90.17%
OM growth 3Y-22.42%
OM growth 5Y-25.56%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.4%
GM growth 5Y-0.4%
S30.PA Yearly Profit, Operating, Gross MarginsS30.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so S30 is destroying value.
Compared to 1 year ago, S30 has about the same amount of shares outstanding.
The number of shares outstanding for S30 remains at a similar level compared to 5 years ago.
S30 has a better debt/assets ratio than last year.
S30.PA Yearly Shares OutstandingS30.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
S30.PA Yearly Total Debt VS Total AssetsS30.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

S30 has an Altman-Z score of 1.66. This is a bad value and indicates that S30 is not financially healthy and even has some risk of bankruptcy.
S30 has a Altman-Z score of 1.66. This is in the lower half of the industry: S30 underperforms 70.42% of its industry peers.
The Debt to FCF ratio of S30 is 4.26, which is a neutral value as it means it would take S30, 4.26 years of fcf income to pay off all of its debts.
S30 has a Debt to FCF ratio (4.26) which is in line with its industry peers.
S30 has a Debt/Equity ratio of 1.27. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of S30 (1.27) is worse than 74.65% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.27
Debt/FCF 4.26
Altman-Z 1.66
ROIC/WACC0.88
WACC4.41%
S30.PA Yearly LT Debt VS Equity VS FCFS30.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.3 Liquidity

A Current Ratio of 0.96 indicates that S30 may have some problems paying its short term obligations.
The Current ratio of S30 (0.96) is worse than 76.06% of its industry peers.
S30 has a Quick Ratio of 0.96. This is a bad value and indicates that S30 is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of S30 (0.90) is worse than 76.06% of its industry peers.
Industry RankSector Rank
Current Ratio 0.96
Quick Ratio 0.9
S30.PA Yearly Current Assets VS Current LiabilitesS30.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

4

3. Growth

3.1 Past

The earnings per share for S30 have decreased strongly by -87.74% in the last year.
S30 shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -10.35%.
The Revenue has been growing slightly by 7.57% on average over the past years.
EPS 1Y (TTM)-87.74%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-185.45%
Revenue 1Y (TTM)-10.35%
Revenue growth 3Y4.45%
Revenue growth 5Y7.57%
Sales Q2Q%-9.66%

3.2 Future

S30 is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 74.72% yearly.
Based on estimates for the next years, S30 will show a quite strong growth in Revenue. The Revenue will grow by 9.22% on average per year.
EPS Next Y66.67%
EPS Next 2Y103.31%
EPS Next 3Y74.72%
EPS Next 5YN/A
Revenue Next Year3.56%
Revenue Next 2Y7.39%
Revenue Next 3Y9.3%
Revenue Next 5Y9.22%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
S30.PA Yearly Revenue VS EstimatesS30.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 500M 1B 1.5B
S30.PA Yearly EPS VS EstimatesS30.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.2 0.4

7

4. Valuation

4.1 Price/Earnings Ratio

S30 reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
S30 is valuated cheaply with a Price/Forward Earnings ratio of 6.45.
91.55% of the companies in the same industry are more expensive than S30, based on the Price/Forward Earnings ratio.
S30 is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.86, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 6.45
S30.PA Price Earnings VS Forward Price EarningsS30.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

90.14% of the companies in the same industry are more expensive than S30, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, S30 is valued cheaper than 97.18% of the companies in the same industry.
Industry RankSector Rank
P/FCF 2.8
EV/EBITDA 3.57
S30.PA Per share dataS30.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

S30's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
S30's earnings are expected to grow with 74.72% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y103.31%
EPS Next 3Y74.72%

0

5. Dividend

5.1 Amount

No dividends for S30!.
Industry RankSector Rank
Dividend Yield N/A

SOLUTIONS 30 SE

EPA:S30 (9/22/2025, 11:45:14 AM)

1.043

+0.01 (+0.58%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)09-17 2025-09-17
Earnings (Next)11-05 2025-11-05
Inst Owners2.27%
Inst Owner ChangeN/A
Ins Owners16.17%
Ins Owner ChangeN/A
Market Cap111.74M
Analysts77.14
Price Target1.94 (86%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-171.43%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 6.45
P/S 0.11
P/FCF 2.8
P/OCF 1.92
P/B 1.2
P/tB N/A
EV/EBITDA 3.57
EPS(TTM)-0.25
EYN/A
EPS(NY)0.16
Fwd EY15.49%
FCF(TTM)0.37
FCFY35.71%
OCF(TTM)0.54
OCFY52%
SpS9.3
BVpS0.87
TBVpS-0.6
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.23%
ROE -17.03%
ROCE 5.29%
ROIC 3.88%
ROICexc 3.89%
ROICexgc 9.73%
OM 1.4%
PM (TTM) N/A
GM 90.17%
FCFM 4.01%
ROA(3y)-4.19%
ROA(5y)-0.94%
ROE(3y)-25.27%
ROE(5y)-8.32%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y18.76%
ROICexcg growth 5Y4.57%
ROICexc growth 3Y-11.4%
ROICexc growth 5Y-15.36%
OM growth 3Y-22.42%
OM growth 5Y-25.56%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.4%
GM growth 5Y-0.4%
F-Score5
Asset Turnover1.4
Health
Industry RankSector Rank
Debt/Equity 1.27
Debt/FCF 4.26
Debt/EBITDA 1.49
Cap/Depr 28.13%
Cap/Sales 1.83%
Interest Coverage 4.34
Cash Conversion 73.92%
Profit Quality N/A
Current Ratio 0.96
Quick Ratio 0.9
Altman-Z 1.66
F-Score5
WACC4.41%
ROIC/WACC0.88
Cap/Depr(3y)33.48%
Cap/Depr(5y)33.85%
Cap/Sales(3y)2.09%
Cap/Sales(5y)2.12%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-87.74%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-185.45%
EPS Next Y66.67%
EPS Next 2Y103.31%
EPS Next 3Y74.72%
EPS Next 5YN/A
Revenue 1Y (TTM)-10.35%
Revenue growth 3Y4.45%
Revenue growth 5Y7.57%
Sales Q2Q%-9.66%
Revenue Next Year3.56%
Revenue Next 2Y7.39%
Revenue Next 3Y9.3%
Revenue Next 5Y9.22%
EBIT growth 1Y67.47%
EBIT growth 3Y-18.97%
EBIT growth 5Y-19.92%
EBIT Next Year887.31%
EBIT Next 3Y139.88%
EBIT Next 5YN/A
FCF growth 1Y219.2%
FCF growth 3Y12.15%
FCF growth 5Y-3.78%
OCF growth 1Y70.38%
OCF growth 3Y6.91%
OCF growth 5Y-1.82%